William Blair Downgrades Allergen (AGN) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Ackman Will Withdraw Request for Special Allergan (AGN) Meeting - CNBC
November 18, 2014 10:24 AM ESTPershing Squares Bill Ackman says he's withdrawing his request for a special Allergan (NYSE: AGN) meeting, according to CNBC.
... MoreWells Fargo Downgrades Allergen (AGN) to Market Perform
November 18, 2014 8:00 AM ESTWells Fargo downgraded Allergen (NYSE: AGN) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreSunTrust Downgrades Allergen (AGN) to Neutral
November 18, 2014 6:39 AM ESTSunTrust Robinson Humphrey downgraded Allergen (NYSE: AGN) from Buy to Neutral.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreGuggenheim Downgrades Allergen (AGN) to Neutral on Takeover
November 18, 2014 6:31 AM ESTGuggenheim downgraded Allergen (NYSE: AGN) from Buy to Neutral but raises its price target to $220.00 following the Actavis (ACT) acqusition.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreActavis (ACT) Agrees to Acquire Allergan (AGN) for ~$219/Share
November 17, 2014 9:15 AM EST(Updated - November 17, 2014 9:16 AM EST)
Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on November 14, 2014, the transaction is valued at approximately $66 billion, or $219 per Allergan share. The combination will create one of the top 10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than... More
Actavis (ACT), Allergan (AGN) Said Nearing $62.5B Deal (VRX)
November 16, 2014 3:53 PM ESTActavis plc (NYSE: ACT) is said to be near a $62.5 billion deal to acquire Allergan (NYSE: AGN).
Bloomberg said Sunday that the deal, which as Actavis paying just over $210 per share for... More
